Let us take you inside AspyreRx™, the first-ever FDA-authorized Prescription Digital Therapeutic for adults with Type 2 Diabetes (T2D). AspyreRx offers a novel form of cognitive behavioral therapy (CBT), tailored specifically for managing and treating T2D, conveniently accessible on smartphones.
Backed by extensive development and safety and efficacy data from a randomized controlled trial involving 668 participants, AspyreRx has demonstrated a statistically significant reduction in HbA1c levels and improved overall health measures.
• Discover how this digital therapeutic works, harnessing the power of technology and psychology to empower patients living with T2D.
• Gain valuable insights into the clinical data, understanding the impact AspyreRx has on managing this chronic condition.
Register today to learn how AspyreRx is empowering people with Type 2 Diabetes.
This 60-minute activity was originally presented on 12/14/2023.
This activity is designed for
individual or groups of diabetes care and education specialists, including nurses,
dietitians, dietetic technicians, pharmacists, pharmacy technicians, nurse practitioners,
clinical nurse specialists, physicians, PAs, social workers, and other health
care providers interested in staying up to date on current practices of care
for people with diabetes and other related conditions.
This educational program does not provide certification on the product discussed. There is no CE/CME credit for this activity.
This educational introduction to AspyreRx™ is sponsored by Better Therapeutics.
Please visit our website www.Aspyrerx.com to learn more.
For more information on AspyreRx including prescribing information & cost and coverage, please contact Christian Meyer, Head of Sales, Better Therapeutics at [email protected] or 617-388-6074.